Evolving Cancer Diagnosis with Cellomics! Cellomics is a leading Hong Kong-based biotech company focusing on the development and commercialization of liquid biopsy products and services for early screening and disease management of cancer. With proprietary microfluidics and nucleic acid detection technology, we offer comprehensive liquid biopsy solutions for precision oncology. We are helping the doctors and patients in winning the war against cancer.